Vor Biopharma (VOR) Current Leases (2020 - 2026)
Vor Biopharma's (VOR) quarterly Current Leases came in at $307000.0 in Q1 2026, down 92.8% year-on-year from $4.3 million in Q1 2025, and up 9.64% on a QoQ basis from $280000.0 in Q4 2025.
Vor Biopharma (VOR) Current Leases (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Current Leases data on file, last reported at $307000.0 in Q1 2026.
- On a quarterly basis, Current Leases fell 92.8% year-over-year to $307000.0 in Q1 2026; TTM through Mar 2026 was $307000.0, a 92.8% decrease from a year earlier, with the FY2025 full-year figure at $280000.0, down 93.36% from the prior year.
- Current Leases for Q1 2026 stood at $307000.0, up from $280000.0 in the prior quarter.
- Over the last five years, Current Leases for VOR reached as high as $7.3 million in Q1 2022 and fell as low as $252000.0 in Q3 2025.
- Historically, Current Leases has averaged $3.5 million across 5 years, with a median of $3.8 million in 2022.
- Across the five-year window, Current Leases soared 530.39% in 2022 and plunged 93.95% in 2025, its largest moves.
- Year by year, Current Leases stood at $3.3 million in 2022, then rose by 17.05% to $3.8 million in 2023, then advanced by 10.05% to $4.2 million in 2024, then plunged by 93.36% to $280000.0 in 2025, then rose by 9.64% to $307000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $307000.0 in Q1 2026, $280000.0 in Q4 2025, and $252000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Vor Biopharma | 187.37 Mn | 187.37 Mn | - | 307,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 307,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 252,000.00 |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | 4.22 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 3.76 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | 1.16 Mn |